284 related articles for article (PubMed ID: 25590559)
41. Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review.
Shu Y; Liu Y; Bian S; Xie Z; Liao C
Mini Rev Med Chem; 2023; 23(1):67-79. PubMed ID: 35657046
[TBL] [Abstract][Full Text] [Related]
42. Centrosome amplification, chromosome instability and cancer development.
Fukasawa K
Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
[TBL] [Abstract][Full Text] [Related]
43. Nek2A kinase regulates the localization of numatrin to centrosome in mitosis.
Yao J; Fu C; Ding X; Guo Z; Zenreski A; Chen Y; Ahmed K; Liao J; Dou Z; Yao X
FEBS Lett; 2004 Sep; 575(1-3):112-8. PubMed ID: 15388344
[TBL] [Abstract][Full Text] [Related]
44. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.
Lane HA; Nigg EA
J Cell Biol; 1996 Dec; 135(6 Pt 2):1701-13. PubMed ID: 8991084
[TBL] [Abstract][Full Text] [Related]
45. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
[TBL] [Abstract][Full Text] [Related]
46. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Wang W; Budhu A; Forgues M; Wang XW
Nat Cell Biol; 2005 Aug; 7(8):823-30. PubMed ID: 16041368
[TBL] [Abstract][Full Text] [Related]
47. Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.
Kawakami M; Mustachio LM; Zheng L; Chen Y; Rodriguez-Canales J; Mino B; Kurie JM; Roszik J; Villalobos PA; Thu KL; Silvester J; Cescon DW; Wistuba II; Mak TW; Liu X; Dmitrovsky E
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1913-1918. PubMed ID: 29434041
[TBL] [Abstract][Full Text] [Related]
48. Targeting the centrosome and polo-like kinase 4 in osteosarcoma.
Kelleher FC; Kroes J; Lewin J
Carcinogenesis; 2019 Jun; 40(4):493-499. PubMed ID: 30508038
[TBL] [Abstract][Full Text] [Related]
49. BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells.
Izumi H; Matsumoto Y; Ikeuchi T; Saya H; Kajii T; Matsuura S
Oncogene; 2009 Aug; 28(31):2806-20. PubMed ID: 19503101
[TBL] [Abstract][Full Text] [Related]
50. The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability.
Nam HJ; Chae S; Jang SH; Cho H; Lee JH
Carcinogenesis; 2010 Sep; 31(9):1531-40. PubMed ID: 20584748
[TBL] [Abstract][Full Text] [Related]
51. Dynamic changes in nuclear architecture during mitosis: on the role of protein phosphorylation in spindle assembly and chromosome segregation.
Nigg EA; Blangy A; Lane HA
Exp Cell Res; 1996 Dec; 229(2):174-80. PubMed ID: 8986594
[TBL] [Abstract][Full Text] [Related]
52. Loss of KLF14 triggers centrosome amplification and tumorigenesis.
Fan G; Sun L; Shan P; Zhang X; Huan J; Zhang X; Li D; Wang T; Wei T; Zhang X; Gu X; Yao L; Xuan Y; Hou Z; Cui Y; Cao L; Li X; Zhang S; Wang C
Nat Commun; 2015 Oct; 6():8450. PubMed ID: 26439168
[TBL] [Abstract][Full Text] [Related]
53. Induction of centrosome amplification in p53 siRNA-treated human fibroblast cells by radiation exposure.
Kawamura K; Morita N; Domiki C; Fujikawa-Yamamoto K; Hashimoto M; Iwabuchi K; Suzuki K
Cancer Sci; 2006 Apr; 97(4):252-8. PubMed ID: 16630116
[TBL] [Abstract][Full Text] [Related]
54. RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts.
Zhang X; Hagen J; Muniz VP; Smith T; Coombs GS; Eischen CM; Mackie DI; Roman DL; Van Rheeden R; Darbro B; Tompkins VS; Quelle DE
PLoS One; 2013; 8(11):e80228. PubMed ID: 24282525
[TBL] [Abstract][Full Text] [Related]
55. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
[TBL] [Abstract][Full Text] [Related]
56. Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics.
Byrne DP; Clarke CJ; Brownridge PJ; Kalyuzhnyy A; Perkins S; Campbell A; Mason D; Jones AR; Eyers PA; Eyers CE
Biochem J; 2020 Jul; 477(13):2451-2475. PubMed ID: 32501498
[TBL] [Abstract][Full Text] [Related]
57. NFκB regulates expression of Polo-like kinase 4.
Ledoux AC; Sellier H; Gillies K; Iannetti A; James J; Perkins ND
Cell Cycle; 2013 Sep; 12(18):3052-62. PubMed ID: 23974100
[TBL] [Abstract][Full Text] [Related]
58. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
59. The centrosome in normal and transformed cells.
Wang Q; Hirohashi Y; Furuuchi K; Zhao H; Liu Q; Zhang H; Murali R; Berezov A; Du X; Li B; Greene MI
DNA Cell Biol; 2004 Aug; 23(8):475-89. PubMed ID: 15307950
[TBL] [Abstract][Full Text] [Related]
60. Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4).
Cizmecioglu O; Krause A; Bahtz R; Ehret L; Malek N; Hoffmann I
J Cell Sci; 2012 Feb; 125(Pt 4):981-92. PubMed ID: 22399798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
